Collection: Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80% while improving article selection accuracy by 37%. It ensures faster, more reliable safety signal detection without sacrificing oversight, helping manage the overwhelming flow of data to protect patient safety.
-
Safety Shield Study for MINOCYCLINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MINOXIDIL
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MOMETASONE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MONOBENZONE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MONTELUKAST
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MOXIDECTIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MOXIFLOXACIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MUPIROCIN
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MYCOPHENOLATE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for MYCOPHENOLATE MOFETIL
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NAFTIFINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NALBUPHINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NALFURAFINE
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NEMOLIZUMAB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NERATINIB
Regular price From €800,00 EURRegular priceUnit price / per -
Safety Shield Study for NIACINAMIDE
Regular price From €800,00 EURRegular priceUnit price / per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...